信測標準(300938.SZ)擬與江蘇益生、常州誠領共設常州信測
格隆匯 3 月 8日丨信測標準(300938.SZ)公佈,為促進公司檢驗檢測業務在“長三角”的發展,公司擬與江蘇益生添健淨化科技有限公司(“江蘇益生”)和常州市誠領技術服務合夥企業(有限合夥)共同出資人民幣1000萬元,設立“常州信測標準技術服務有限公司”(“常州信測”,最終以工商行政管理部門最終核定名稱為準)。其中公司認繳人民幣510萬元,佔註冊資本的51%;江蘇益生認繳人民幣260萬元,佔註冊資本的26%;常州誠領認繳人民幣230萬元,佔註冊資本的23%。
信測標準的戰略目標是成為國內領先的第三方品質管控服務機構,為國內企業提供全方位的品質管控解決方案。基於公司戰略規劃和經營發展的需求,通過在常州市設立控股子公司拓展檢驗檢測業務,增強公司在“長三角”地區市場開拓及本地項目承接能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.